🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
38Score
DipBuster Score™
$25.22
$0.7 (0%)
Live price · Source: FMP-live
52-Week Position
$23.11
37% of range
$28.75
Beta
0.295
Low vol
Dividend
—
no income
Mkt Cap
$143.74B
total value
Mkt Cap$143.74B
P/EN/A
DividendNone
Beta0.295
52W High$28.75
52W Low$23.11
🤖
Watch — Score 38/100
Zone: Buy Zone
🔒 Unlock Pro
Valuation
P/E Ratio—
Mkt Cap$143.74B
52W Position37% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.295
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️
Insider Buys
Track director & CEO open-market purchases
📊
Valuation Analysis
P/E, EV/EBITDA, DCF & NCAV metrics
📈
Financial Charts
Revenue, EBITDA, FCF & balance sheet trends
🤖
AI Analysis
Plain-English explanation of every key metric
Sign up free — charts & fundamentals included
Get financial charts, valuation data, dividends & news for Pfizer Inc. free. Upgrade to Pro for insider signals & AI analysis.
Sponsored · FCA Regulated Broker
Freetrade
Simple investing app. Free ISA. UK and US stocks. FCA regulated.
Free share when you fund your account
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
25/25
Momentum & Volume
8/25
Quality & Size
5/10
Insider Activity
0/10
Quick Take
🟡
Watch
DipBuster Score: 38/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addr…
Sector
Pharmaceuticals
Market
🇺🇸 US
CEO
Albert Bourla
Staff
81,000 employees
Website